Over the past decade, PCR testing for infectious agents in the clinical laboratory has begun to replace other methods, such as culture. PCR is often now referred to as the gold standard in this field.

Venlo, the Netherlands, Sept. 30, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition ...

健康相談サービスやオンライン診察アプリ等の開発・運用を行う合同会社MASAI Medical（代表社員：山田恵理、本社所在地：大阪府大阪市）は、新型コロナウイルス感染症に特化した医師によるオンライン診察とPCR検査「MedLab -メドラボ-」を提供しておりますが ...

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...

健康相談サービスやオンライン診察アプリ等の開発・運用を行う合同会社MASAI Medical（代表社員：山田恵理、本社所在地：大阪府大阪市）は、新型コロナウイルス感染症に特化した『医師によるオンライン診察×在宅のままできるPCR検査（医師の遠隔指導下で ...

SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ --Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...

Agilent Technologies has expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument ...

LONDON, July 18, 2017 /PRNewswire/ -- The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) ...

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests. The suit, filed in a Texas ...

CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, "We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025." Egan ...